Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders.

about

mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model.

P2860

Q54978861-602230BF-87B5-4017-9FF1-E9D860E08B74

P2860

Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders.

Item

http://www.wikidata.org/entity/Q47136331

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Everolimus for treatment of tu ...... ed neuropsychiatric disorders.

@en

Everolimus for treatment of tu ...... ed neuropsychiatric disorders.

@nl

type

Item

label

Everolimus for treatment of tu ...... ed neuropsychiatric disorders.

@en

Everolimus for treatment of tu ...... ed neuropsychiatric disorders.

@nl

prefLabel

Everolimus for treatment of tu ...... ed neuropsychiatric disorders.

@en

Everolimus for treatment of tu ...... ed neuropsychiatric disorders.

@nl

P1476

Everolimus for treatment of tu ...... ed neuropsychiatric disorders.

@en

P2093

Anjali Sadhwani

http://www.w3.org/2001/XMLSchema#string

Anna W Byars

http://www.w3.org/2001/XMLSchema#string

David N Franz

http://www.w3.org/2001/XMLSchema#string

Donna Murray

http://www.w3.org/2001/XMLSchema#string

Kush Kapur

http://www.w3.org/2001/XMLSchema#string

Petrus J de Vries

http://www.w3.org/2001/XMLSchema#string

Rajna Filip-Dhima

http://www.w3.org/2001/XMLSchema#string

Vicky H Whittemore

http://www.w3.org/2001/XMLSchema#string

P2860

mTOR signaling in growth control and disease

Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis

The neurology of mTOR

Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference

Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2

Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage.

Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures.

Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex.

Atypical face processing in children with tuberous sclerosis complex.

P304

877-887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACN3.494

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mustafa Sahin

Darcy A Krueger

P577

2017-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29296616

http://www.w3.org/2001/XMLSchema#string

P932

5740257

http://www.w3.org/2001/XMLSchema#string

Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders.

about

P2860

P2860

Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932